In: Non-small cell lung cancer

Aglatimagene besadenovec

Candel Therapeutics · CAN-2409

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 2 trial completes
Trials
5 active
13 in total
Targets
—
None known yet

What this is

How it works
Gene therapy: adenovirus carrying a herpes virus enzyme gene, given with a prodrug
How it’s given
“Patients will receive three courses of ProstAtak® each consisting of aglatimagene besadenovec injection + oral valacyclovir. AdV-tk injection will be delivered to the prostate via trans-rectal ultrasound guided injection as follows: 1. The first injection will be given at least 15 days and not more than 8 weeks before starting radiation. 2. The second injection will be 0-3 days before initiation…”In the company’s words, NCT01436968 on ClinicalTrials.gov
Tested for
Prostate Cancer (2 trials), Non-squamous, Non-Small Cell Lung Cancer, Non Small Cell Lung Cancer, Prostate Cancer Patients Treated by Radiotherapy, Prostate Cancer (Adenocarcinoma)
Main trialPhase 3
“The purpose of this study is to evaluate the effectiveness of ProstAtak® immunotherapy in combination with radiation therapy for patients with intermediate-high risk localized prostate cancer. ProstAtak kills tumor cells and stimulates a cancer vaccine effect. Killing tumor cells in an immune stimulatory environment induces the body's immune system to detect and destroy cancer cells. ProstAtak has shown synergy with radiation without added toxicity and lower than expected recurrence rates in previous clinical trials. The hypothesis is that ProstAtak can lead to improvement in the clinical…”In the company’s words, NCT01436968 on ClinicalTrials.gov
Other names
CAN-2409 · AdV-tk

Other drugs for Prostate Cancer

All 194 drugs for Prostate Cancer

Coming up2

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials13

TrialPhaseCompletesWhat it tests
Phase 3Active, not recruiting Aug 2024 Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer
Phase 3Recruiting 22 Oct 2031 Aglatimagene Besadenovec + Prodrug and Pembrolizumab vs Docetaxel for Stage IV Non-Squamous NSCLC Progressing on Pembrolizumab (AURORA)
Phase 2Active, not recruiting Nov 2024 Randomized Controlled Trial of CAN-2409 Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES)
Phase 2Active, not recruiting 31 Dec 2024 CAN-2409 Plus Prodrug With Standard of Care Immune Checkpoint Inhibitor for Stage III/IV NSCLC
Phase 2Recruiting Feb 2027 A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec
Phase 2Completed Dec 2015 Phase 2a Study of CAN-2409 With Standard Radiation Therapy for Malignant Glioma
Phase 2Unknown Dec 2025 Neoadjuvant CAN-2409 in Combination With Chemoradiation or SBRT for Borderline Resectable Pancreatic Adenocarcinoma
Phase 1Completed Jan 2010 Phase 1b Study of AdV-tk + Valacyclovir Combined With Radiation Therapy for Malignant Gliomas
Phase 1Completed May 2013 AdV-tk Therapy With Surgery and Chemoradiation for Pancreas Cancer (PaTK01)
Phase 1Completed Dec 2015 A Phase I Study of AdV-tk + Prodrug Therapy in Combination With Radiation Therapy for Pediatric Brain Tumors
Phase 1Completed Dec 2015 Intrapleural AdV-tk Therapy in Patients With Malignant Pleural Effusion
Phase 1Completed 1 Dec 2021 Intratumoral Gene Mediated Cytotoxic Immunotherapy in Patients With Resectable Non-Small Cell Lung Cancer
Phase 1Completed 30 Jun 2023 GMCI, Nivolumab, and Radiation Therapy in Treating Patients With Newly Diagnosed High-Grade Gliomas
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Aglatimagene besadenovec

Following is part of Solo: you see every change to Aglatimagene besadenovec the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in